Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
N Engl J Med. 2021 Feb 11;384(6):497-511. doi: 10.1056/NEJMoa2023184. Epub 2020 Dec 2.
N Engl J Med. 2021.
PMID: 33264556
Free PMC article.
Clinical Trial.
Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
WHO Solidarity Trial Consortium.
WHO Solidarity Trial Consortium.
Lancet. 2022 May 21;399(10339):1941-1953. doi: 10.1016/S0140-6736(22)00519-0. Epub 2022 May 2.
Lancet. 2022.
PMID: 35512728
Free PMC article.
Item in Clipboard
Health Research Priority Agenda for Ministry of Health, Kingdom of Saudi Arabia from 2020 to 2025.
Alotaibi A, Saleh W, Abdulbaqi A, Alosaimi M.
Alotaibi A, et al.
J Epidemiol Glob Health. 2022 Dec;12(4):413-429. doi: 10.1007/s44197-022-00061-5. Epub 2022 Oct 4.
J Epidemiol Glob Health. 2022.
PMID: 36195693
Free PMC article.
Item in Clipboard
Structural Mapping of Mutations in Spike, RdRp and Orf3a Genes of SARS-CoV-2 in Influenza Like Illness (ILI) Patients.
Alosaimi B, Naeem A, Alghoribi MF, Okdah L, Hamed ME, AlYami AS, Alotaibi A, Enani M.
Alosaimi B, et al. Among authors: alotaibi a.
Viruses. 2021 Jan 19;13(1):136. doi: 10.3390/v13010136.
Viruses. 2021.
PMID: 33477951
Free PMC article.
Item in Clipboard
Favipiravir and Hydroxychloroquine Combination Therapy in Patients with Moderate to Severe COVID-19 (FACCT Trial): An Open-Label, Multicenter, Randomized, Controlled Trial.
Bosaeed M, Mahmoud E, Alharbi A, Altayib H, Albayat H, Alharbi F, Ghalilah K, Al Arfaj A, AlJishi J, Alarfaj A, Alqahtani H, Almutairi BM, Almaghaslah M, Alyahya NM, Bawazir A, AlEisa S, Alsaedy A, Bouchama A, Alharbi M, AlShamrani M, Al Johani S, Aljeraisy M, Alzahrani M, Althaqafi AO, Almarhabi H, Alotaibi A, Alqahtani N, Arabi YM, Aldibasi OS, Alaskar A.
Bosaeed M, et al. Among authors: alotaibi a.
Infect Dis Ther. 2021 Dec;10(4):2291-2307. doi: 10.1007/s40121-021-00496-6. Epub 2021 Jul 28.
Infect Dis Ther. 2021.
PMID: 34319552
Free PMC article.
Item in Clipboard
Cite
Cite